Clinical Trial Update: Celecoxib in Preventing Skin Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating celecoxib for preventing non-melanoma skin cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Non-melanomatous Skin Cancer | Phase 2 | Status: WITHDRAWN